US Stock MarketDetailed Quotes

CTCX Carmell

Watchlist
  • 2.050
  • -0.130-5.96%
Close May 10 16:00 ET
42.50MMarket Cap-2936P/E (TTM)

About Carmell Company

Carmell Corp. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. Its products include Bone Healing Accelerant and Tissue Healing Accelerant. The company was founded on November 5, 2008 and is headquartered in Pittsburgh, PA.

Company Profile

SymbolCTCX
Company NameCarmell
Listing DateSep 23, 2021
Founded2008
CEOMr. Rajiv Shukla
MarketNASDAQ
Employees10
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address2403 Sidney Street,Suite 300
CityPittsburgh
ProvincePennsylvania
CountryUnited States of America
Zip Code15203
Phone1-412-894-8248
Websitehttp://www.carmellrx.com

Company Executives

  • Name
  • Position
  • Salary
  • Rajiv Shukla
  • Executive Chairman of the Board and Chief Executive Officer
  • --
  • Bryan J. Cassaday
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Patrick A. Sturgeon
  • Director
  • --
  • David Anderson
  • Director
  • --
  • Kathryn Gregory
  • Independent Director
  • --
  • Richard A. Upton
  • Independent Director
  • --
  • Scott Frisch
  • Independent Director
  • --
  • Dr. Gilles Spenlehauer
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg